Tag: Sanofi
Dupixent eczema injection gets FDA approval for atopic dermatitis treatment
Dupixent (dupilumab), the co-developed eczema injection from pharma giants Sanofi and Regeneron Pharmaceuticals, has got the US FDA approval for the treatment of moderate-to-severe atopic ... Read More
AstraZeneca, Sanofi form R&D alliance for infant respiratory drug
AstraZeneca’s MedImmune and Sanofi Pasteur have formed a research and development alliance for a new infant respiratory drug, MEDI8897 which they are planning to commercialize ... Read More
Eczema drug Dupixent succeeds in phase 3 atopic dermatitis clinical trial
Atopic dermatitis clinical trial : The jointly developed eczema drug, Dupixent (dupilumab) from Sanofi and Regeneron Pharmaceuticals has met the primary endpoints of a crucial ... Read More